No abstract available
Keywords:
World Health Organization; endothelin receptor antagonists; heart failure; hypertension, pulmonary; phosphodiesterase 5 inhibitors.
MeSH terms
-
Antihypertensive Agents / therapeutic use*
-
Clinical Trials as Topic
-
Endothelin Receptor Antagonists / therapeutic use*
-
Evidence-Based Medicine
-
Humans
-
Hypertension, Pulmonary / drug therapy*
-
Sildenafil Citrate / therapeutic use*
-
Vascular Remodeling
Substances
-
Antihypertensive Agents
-
Endothelin Receptor Antagonists
-
Sildenafil Citrate